Deutsche Bank AG Acquires 167,918 Shares of Revvity, Inc. (NYSE:RVTY)

Deutsche Bank AG increased its holdings in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 43.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 550,614 shares of the company's stock after purchasing an additional 167,918 shares during the quarter. Deutsche Bank AG owned approximately 0.45% of Revvity worth $61,454,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. raised its position in shares of Revvity by 16.7% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock valued at $2,317,170,000 after buying an additional 2,969,326 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Revvity by 17.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock worth $851,764,000 after purchasing an additional 1,151,821 shares in the last quarter. Norges Bank bought a new position in shares of Revvity during the 4th quarter valued at about $127,801,000. Invesco Ltd. grew its position in shares of Revvity by 18.8% during the fourth quarter. Invesco Ltd. now owns 1,740,933 shares of the company's stock valued at $194,306,000 after purchasing an additional 274,923 shares in the last quarter. Finally, Proficio Capital Partners LLC lifted its position in shares of Revvity by 12,298.3% in the fourth quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company's stock worth $21,850,000 after buying an additional 194,190 shares in the last quarter. Institutional investors own 86.65% of the company's stock.

Revvity Trading Up 8.1%

RVTY stock opened at $98.64 on Tuesday. The company has a market capitalization of $11.63 billion, a PE ratio of 44.63, a P/E/G ratio of 3.82 and a beta of 1.02. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. Revvity, Inc. has a 12 month low of $88.53 and a 12 month high of $129.50. The firm's 50-day moving average is $100.57 and its 200 day moving average is $110.96.

Revvity (NYSE:RVTY - Get Free Report) last issued its earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The business had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. During the same period last year, the company posted $0.98 earnings per share. The company's quarterly revenue was up 2.3% compared to the same quarter last year. On average, research analysts anticipate that Revvity, Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.28%. Revvity's dividend payout ratio is currently 11.91%.

Analyst Ratings Changes

RVTY has been the topic of a number of research reports. Barclays reduced their price objective on Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a research note on Thursday, April 10th. JPMorgan Chase & Co. reduced their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a report on Tuesday, April 29th. Wells Fargo & Company lowered their price target on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a report on Thursday, April 17th. Raymond James reissued an "outperform" rating and set a $120.00 price objective (down from $145.00) on shares of Revvity in a research note on Tuesday, April 29th. Finally, KeyCorp boosted their target price on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Four analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $125.64.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.